Malleability of Short Telomeres by Telomerase Activators: A Mini-review

Most human cells lack sufficient telomerase to maintain telomeres; hence they shorten with each cellular division leading to organismal aging and disabling age-related diseases susceptibility. Genetic studies in mice demonstrated that short telomeres rather than average telomere length are associated with most age-related diseases and that rescue of short telomeres by telomerase is sufficient to restore cell and tissues viability. Novel findings in telomerase activation suggested its role as a new therapeutic strategy to prevent or at least retard cellular senescence and organismal decline, potentially impacting on human health.

[1]  C. Harley,et al.  A natural product telomerase activator as part of a health maintenance program: metabolic and cardiovascular response. , 2013, Rejuvenation research.

[2]  G. Paolisso,et al.  A new pleiotropic effect of statins in elderly: modulation of telomerase activity , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[3]  G. Paolisso,et al.  Mediterranean Diet, Telomere Maintenance and Health Status among Elderly , 2013, PloS one.

[4]  M. Armanios Telomeres and age-related disease: how telomere biology informs clinical paradigms. , 2013, The Journal of clinical investigation.

[5]  E. Epel,et al.  A pilot study of yogic meditation for family dementia caregivers with depressive symptoms: effects on mental health, cognition, and telomerase activity , 2013, International journal of geriatric psychiatry.

[6]  A. Newman,et al.  Telomere length in epidemiology: a biomarker of aging, age-related disease, both, or neither? , 2013, Epidemiologic reviews.

[7]  E. Epel,et al.  Changes in stress, eating, and metabolic factors are related to changes in telomerase activity in a randomized mindfulness intervention pilot study , 2012, Psychoneuroendocrinology.

[8]  V. Boccardi,et al.  Telomerase gene therapy: a novel approach to combat aging , 2012, EMBO molecular medicine.

[9]  Kerstin Schneeberger,et al.  Telomerase gene therapy in adult and old mice delays aging and increases longevity without increasing cancer , 2012, EMBO molecular medicine.

[10]  C. Harley,et al.  The telomerase activator TA‐65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence , 2011, Aging cell.

[11]  Brandon G. King,et al.  Intensive meditation training, immune cell telomerase activity, and psychological mediators , 2011, Psychoneuroendocrinology.

[12]  C. Harley,et al.  A natural product telomerase activator as part of a health maintenance program. , 2011, Rejuvenation research.

[13]  Helen Christensen,et al.  Is telomere length a biomarker of aging? A review. , 2010, The journals of gerontology. Series A, Biological sciences and medical sciences.

[14]  C. Harley,et al.  Telomerase-Based Pharmacologic Enhancement of Antiviral Function of Human CD8+ T Lymphocytes1 , 2008, The Journal of Immunology.

[15]  P. Klatt,et al.  Telomerase Reverse Transcriptase Delays Aging in Cancer-Resistant Mice , 2008, Cell.

[16]  Jue Lin,et al.  Increased telomerase activity and comprehensive lifestyle changes: a pilot study. , 2008, The Lancet. Oncology.

[17]  M. Blasco,et al.  Cellular Senescence in Cancer and Aging , 2007, Cell.

[18]  P. Lansdorp,et al.  Telomerase mutations in families with idiopathic pulmonary fibrosis. , 2007, The New England journal of medicine.

[19]  M. Blasco Telomeres and human disease: ageing, cancer and beyond , 2005, Nature Reviews Genetics.

[20]  S. Chanock,et al.  Mutations in TERT, the gene for telomerase reverse transcriptase, in aplastic anemia. , 2005, The New England journal of medicine.

[21]  M. Blasco,et al.  Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice , 2005, Oncogene.

[22]  K. Collins,et al.  Telomerase in the human organism , 2002, Oncogene.

[23]  T. Lange Protection of mammalian telomeres , 2002, Oncogene.

[24]  Margaret A. Strong,et al.  The Shortest Telomere, Not Average Telomere Length, Is Critical for Cell Viability and Chromosome Stability , 2001, Cell.

[25]  E. Blackburn Switching and Signaling at the Telomere , 2001, Cell.

[26]  M. Blasco,et al.  Restoration of telomerase activity rescues chromosomal instability and premature aging in Terc−/− mice with short telomeres , 2001, EMBO reports.

[27]  María A Blasco,et al.  Telomere Shortening and Tumor Formation by Mouse Cells Lacking Telomerase RNA , 1997, Cell.

[28]  C. Harley,et al.  Telomeres shorten during ageing of human fibroblasts , 1990, Nature.